Clinical Trials

264 enrolled

Advanced Solid Tumors

NCT07623707 2026-06-03

A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors

264 enrolled

Solid Tumor

NCT06833008 2026-06-01

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

85 enrolled

Advanced Solid Tumor

NCT07617493 2026-06-01

Evaluation of ICP-B208 in Patients With Advanced Solid Tumors

539 enrolled

Phase 1/2 Active not recruiting

Advanced Solid Tumor

NCT01064648 2026-05-29

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

117 enrolled 23 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT03585465 2026-05-29

Metro-PD1

Phase 1/2 Terminated

63 enrolled

Phase 1/2 Active not recruiting

Childhood Solid Tumor

NCT04826341 2026-05-29

A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors

35 enrolled

Other solid neoplasmThoracic

HRD Cancer

NCT05886920 2026-05-29

A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

Phase 1/2 Active not recruiting

67 enrolled

Advanced Solid Tumors With MAPK Pathway Mutations

NCT07615660 2026-05-29

CVL006-T1003

108 enrolled

Advanced Solid Tumor

NCT05052268 2026-05-28

XTX202 in Patients With Advanced Solid Tumors

Phase 1/2 Completed

95 enrolled 49 charts

Advanced Solid Tumor

NCT06922357 2026-05-28

A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors

120 enrolled

Advanced/Metastatic Solid Tumors

NCT07469774 2026-05-28

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

111 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT07612137 2026-05-28

Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

282 enrolled

Solid Tumor

NCT05599048 2026-05-27

Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

65 enrolled

Advanced Solid Tumor

NCT07095868 2026-05-27

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

94 enrolled

Selected Types of Solid Tumor

NCT07228247 2026-05-27

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

147 enrolled

Solid Tumors, Adult

NCT06051695 2026-05-26

EVEREST-2

GastrointestinalGynecologicOther solid neoplasmThoracic

474 enrolled

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

NCT07446855 2026-05-26

PARTHENON

180 enrolled

Solid Tumours

NCT05277168 2026-05-22

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

83 enrolled

Advanced Solid Tumors

NCT06656390 2026-05-22

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

202 enrolled

Advanced Cancer

NCT06977737 2026-05-22

ATTEST

72 enrolled

Solid Tumor, Adult

NCT07192432 2026-05-22

SENTRY-HER2

27 enrolled

HER2 Expressing Solid Tumors

NCT07602855 2026-05-22

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

184 enrolled

Solid Tumors

NCT06598371 2026-05-20

A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

141 enrolled

Select Advanced Solid Tumors

NCT07459998 2026-05-18

SKB103 for Injection in Advanced Solid Tumors

277 enrolled

Advanced Solid Tumors

NCT07594028 2026-05-18

Phase I/II Study of SCTB41 Plus SCTB39-1with or Without Standard Therapy in Advanced Solid Tumours

126 enrolled

Advanced Malignant Solid Tumor

NCT04843709 2026-05-15

A Study of MRG004A in Patients With Tissue Factor Positive Advanced or Metastatic Solid Tumors

Phase 1/2 Completed

39 enrolled

Advanced or Metastatic Solid Tumors

NCT05170958 2026-05-15

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

396 enrolled

Advanced Solid Tumor

NCT07160725 2026-05-15

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

315 enrolled

Solid Tumours

NCT07589530 2026-05-15

SOLID-NK

60 enrolled